Most FDA advisers say the BPC-157 and KPV peptides should be made available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.

Source: [MarketWatch](https://www.marketwatch.com/story/peptides-could-soon-become-widely-available-in-the-u-s-heres-what-happens-next-ead02287?mod=mw_rss_topstories)